For women at elevated risk for breast cancer due to a BRCA1 or BRCA2 pathogenic variant, RRM can significantly reduce risk while offering a prognosis and life expectancy comparable to that of surveillance, along with reduced fear. The gene discussed is BRCA2; the disease is breast cancer.